Detalhe da pesquisa
1.
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer.
Curr Oncol Rep
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639793
2.
Decision regret, and other mental health outcomes, following fertility preservation in the transgender individual compared to the cisgender woman.
J Assist Reprod Genet
; 41(4): 1077-1085, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332415
3.
Lower female partner live birth rate in male cancer survivors: An age-matched cohort analysis of the Utah Population Database.
Andrologia
; 54(1): e14293, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34734429
4.
Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen.
J Assist Reprod Genet
; 39(11): 2617-2624, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192617
5.
Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members.
J Assist Reprod Genet
; 39(8): 1749-1757, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35870098
6.
Breast cancer grade and stage do not affect fertility preservation outcomes.
J Assist Reprod Genet
; 39(5): 1155-1161, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320444
7.
Association of multifetal gestation with obstetric and neonatal outcomes in gestational carrier pregnancies.
J Assist Reprod Genet
; 38(3): 661-667, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400079
8.
Obstetric morbidity in gestational carrier pregnancies: a population-based study.
J Assist Reprod Genet
; 38(1): 177-183, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145724
9.
Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience.
J Assist Reprod Genet
; 38(11): 2955-2963, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34613578
10.
Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients.
J Assist Reprod Genet
; 38(7): 1755-1765, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740176
11.
Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
J Assist Reprod Genet
; 38(9): 2455-2463, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312774
12.
Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Cancer
; 126(3): 487-495, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31639215
13.
Current Approaches to Fertility Preservation.
Clin Obstet Gynecol
; 63(4): 735-751, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33136824
14.
Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
J Assist Reprod Genet
; 36(6): 1161-1168, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127475
15.
Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
J Assist Reprod Genet
; 35(2): 309, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29178020
16.
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
J Assist Reprod Genet
; 35(2): 297-307, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29086322
17.
Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Breast Cancer Res Treat
; 165(1): 151-159, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28503722
18.
Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Hum Reprod
; 32(3): 568-574, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122888
19.
Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Hum Reprod
; 32(10): 2123-2129, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28938748
20.
Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.
J Assist Reprod Genet
; 34(9): 1137-1144, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28669055